Single-cell landscape of immunological responses in CTLA4 haploinsufficiency patient after abatacept therapy. (PubMed, Clin Exp Rheumatol) - Sep 18, 2026 - "These results offer a theoretical foundation for utilisation of abatacept in CTLA4 haploinsufficiency and have significant implications for understanding the mechanism of immune checkpoints."
IO biomarker • Journal • CTLA4
|
|
Chi Shao; Di Wu; Hao Zhao; Min Shen; Na Wu; Xiaofeng Zeng; Xu Jiang; Xuefeng Sun; Yangzhige He
|